Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013

BACKGROUND: Since 2005, the Togo National Malaria Control Programme has recommended two different formulations of artemisinin-based combination therapy (ACT), artesunate–amodiaquine (ASAQ) and artemether-lumefantrine (AL), for the treatment of uncomplicated malaria. Regular efficacy monitoring of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorkenoo, Améyo M., Yehadji, Degninou, Agbo, Yao M., Layibo, Yao, Agbeko, Foli, Adjeloh, Poukpessi, Yakpa, Kossi, Sossou, Efoe, Awokou, Fantchè, Ringwald, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917981/
https://www.ncbi.nlm.nih.gov/pubmed/27334876
http://dx.doi.org/10.1186/s12936-016-1381-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917981/
https://www.ncbi.nlm.nih.gov/pubmed/27334876
http://dx.doi.org/10.1186/s12936-016-1381-8

Ejemplares similares